CEimpact Podcast

Acetazolamide for Diuresis in Hospitalized Heart Failure Patients

October 17, 2022 CEimpact
CEimpact Podcast
Acetazolamide for Diuresis in Hospitalized Heart Failure Patients
Show Notes

Studies suggest that patients admitted to the hospital with heart failure are inadequately diuresed before discharge. Join host, Geoff Wall, as he reviews the data on acetazolamide for diuresis in heart failure.

The GameChanger
Augmentation of loop diuretics with acetazolamide significantly increases diuresis in persons with heart failure.

Geoff produces music under the name, Prophets of Jupiter. This is the song he mentions at the end of the episode - Time to Dance - Lola K Remix.

The COVID-19 pandemic is still ‘a thing’ and the best source of protection are vaccines. The new bivalent booster vaccine provides opportunities to protect ourselves and our communities. If you, your pharmacist, or technicians need Immunization Training – check out CEimpact’s VIRTUAL Administration Training.  Use discount code THANKYOU to save 10%.

Show Segments
00:00 - Introductions

02:15 - Current Use of IV Diuretics

06:15 - Background on Acetazolamide

08:22 - The ADVOR Study

18:38  - Gamechanger: Study Results

20:32 - Connecting to Practice

25:35 - Closing Remarks

Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources
Acetazolamide in Acute Decompensated Heart Failure with Volume Overload

Redeem your CPE or CME here

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

CE Information
Learning Objectives

Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the ADVOR study design
2. Describe the main adverse effects of acetazolamide

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-372-H01-P
Initial release date: 10/17/2022
Expiration date: 10/17/2023
Additional CPE and CME details can be found here

Follow CEimpact on Social Media: